Efficacy and safety of linagliptin in Hispanic/Latino patients with type 2 diabetes mellitus: a pooled analysis from six randomized placebo-controlled phase 3 trials

OBJECTIVE: The number of individuals diagnosed with type 2 diabetes mellitus is expected to rise disproportionately in Hispanic/Latino populations. We therefore aimed to assess the efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin specifically in Hispanic/Latino patients with t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Davidson, Jaime A, Lajara, Rosemarie, Aguilar, Richard B, Mattheus, Michaela, Woerle, Hans-Juergen, von Eynatten, Maximilian
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2014
Matèries:
Perspectives in Diabetes
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4212575/
https://ncbi.nlm.nih.gov/pubmed/25452864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2014-000020
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars